FYI - FDA Announces new safety plan for anemia drugs
jamilou
Member Posts: 200
Found this information today on FDA approval of new safety plan for drugs such as Epogen, Procrit and Aranesp.
Here is some of the info:
Many cancer patients take ESAs or receive blood transfusions to reduce the effects of chemotherapy induced anemia. Recent studies have shown tumor growth or increased mortality in some cancers prompting numerous regulatory changes, including this REMS.
Patients will have to receive ESAs from a certified provider who has completed education about the drug and will discuss the risks and benefits of the drug. Patients will be required to sign a form confirming that they have had such a conversation, and potentially other forms as well.
The purpose of this program, according to the FDA, is to allow patients access to information that can help them make more informed choices. The goals of any patient’s treatment plan should be discussed with the patient’s doctor as the goals for a curative care plan may differ from that of a palliative plan. It is therefore important for patients receiving chemotherapy to weigh the risks and benefits carefully, in light of their individual treatment plan.
The REMS instituted is based on evidence that showed that “ESAs cause tumors to grow faster or resulted in earlier death for cancer patients,” states Richard Pazdur, M.D., Director, Office of Oncology Drug Products, CDER, FDA. Patients should consider the risks and benefits of any drugs, including ESAs.
Hope this info is useful
Jami
Here is some of the info:
Many cancer patients take ESAs or receive blood transfusions to reduce the effects of chemotherapy induced anemia. Recent studies have shown tumor growth or increased mortality in some cancers prompting numerous regulatory changes, including this REMS.
Patients will have to receive ESAs from a certified provider who has completed education about the drug and will discuss the risks and benefits of the drug. Patients will be required to sign a form confirming that they have had such a conversation, and potentially other forms as well.
The purpose of this program, according to the FDA, is to allow patients access to information that can help them make more informed choices. The goals of any patient’s treatment plan should be discussed with the patient’s doctor as the goals for a curative care plan may differ from that of a palliative plan. It is therefore important for patients receiving chemotherapy to weigh the risks and benefits carefully, in light of their individual treatment plan.
The REMS instituted is based on evidence that showed that “ESAs cause tumors to grow faster or resulted in earlier death for cancer patients,” states Richard Pazdur, M.D., Director, Office of Oncology Drug Products, CDER, FDA. Patients should consider the risks and benefits of any drugs, including ESAs.
Hope this info is useful
Jami
0
Comments
-
Thanks for info
Hi there Jamilou,
Thanks for the information. I had an oncologist mention this to me about a year ago. It's very scary since I have to get Arnesp everytime I have chemo, and my marker has been going up, up. The day that the doctor told me this information, we opted for me to not have the shot, and my RBC spiraled down to around 7.0 after the chemo. With the Arnesp, it stays at 10.0 at least. What should we do? Any opinions, girls? Take good care everyone, and thanks again Jamilou!!!! Luv and hugs, MM0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.7K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 308 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 395 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.3K Kidney Cancer
- 670 Leukemia
- 792 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 236 Multiple Myeloma
- 7.1K Ovarian Cancer
- 59 Pancreatic Cancer
- 486 Peritoneal Cancer
- 5.4K Prostate Cancer
- 1.2K Rare and Other Cancers
- 537 Sarcoma
- 727 Skin Cancer
- 652 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards